Using PSMA imaging for prognostication in localized and advanced prostate cancer
MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …
prostate cancer management has evolved rapidly over the past few years, helping to …
Prostate-specific membrane antigen PET in prostate cancer
C Lawhn-Heath, A Salavati, SC Behr, SP Rowe… - Radiology, 2021 - pubs.rsna.org
Prostate-specific membrane antigen (PSMA)–targeted radiopharmaceuticals are playing a
large role at the time of initial staging and biochemical recurrence for localizing prostate …
large role at the time of initial staging and biochemical recurrence for localizing prostate …
[HTML][HTML] E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET
Rationale The development of consensus guidelines for interpretation of Prostate-Specific
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide …
Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide …
[HTML][HTML] Prostate-specific membrane antigen (PSMA) theranostics for treatment of oligometastatic prostate cancer
Theranostics, a combination of therapy and diagnostics, is a field of personalized medicine
involving the use of the same or similar radiopharmaceutical agents for the diagnosis and …
involving the use of the same or similar radiopharmaceutical agents for the diagnosis and …
PET imaging for prostate cancer
The role of PET imaging with11C-choline and18F-fluciclovine in evaluating patients with
prostate cancer (PCa) has become more important over the years and has been …
prostate cancer (PCa) has become more important over the years and has been …
[HTML][HTML] 68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective …
Background The primary objective was to compare the overall diagnostic performance,
presented as detection rate of 68 Ga-PSMA-HBED-CC positron emission …
presented as detection rate of 68 Ga-PSMA-HBED-CC positron emission …
Prostate-specific membrane antigen targeted PET/CT for recurrent prostate cancer: a clinician's guide
ABSTRACT Introduction PSMA-targeted PET/CT is a 'Next Generation Imaging'technique
with superior sensitivity and specificity for detecting recurrent prostate cancer compared with …
with superior sensitivity and specificity for detecting recurrent prostate cancer compared with …
[HTML][HTML] Prostate-specific membrane antigen (PSMA)-based imaging in localized and advanced prostate cancer: a narrative review
I de Kouchkovsky, R Aggarwal… - … andrology and urology, 2021 - ncbi.nlm.nih.gov
Combined molecular and morphologic imaging modalities have emerged in recent years as
an alternative to conventional imaging in prostate cancer (PC). In particular, novel prostate …
an alternative to conventional imaging in prostate cancer (PC). In particular, novel prostate …
18F‐labeled 1,2,3‐triazole‐linked Glu‐urea‐Lys‐based PSMA ligands have good pharmacokinetic properties for positron emission tomography imaging of prostate …
BS Lee, SY Chu, WJ Jung, HJ Jeong, K Lee… - The …, 2020 - Wiley Online Library
Background Prostate‐specific membrane antigen (PSMA) is increasingly recognized as an
excellent target for prostate cancer imaging and therapy. Finding compounds with a high …
excellent target for prostate cancer imaging and therapy. Finding compounds with a high …
Seek and find: current prospective evidence for prostate-specific membrane antigen imaging to detect recurrent prostate cancer
Context Men with biochemically relapsed prostate cancer face a clinical conundrum.
Depending on the detected distribution of disease, treatment goals may range from cure with …
Depending on the detected distribution of disease, treatment goals may range from cure with …